United States · FDA National Drug Code directory
Fyremadel
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55566-1010_5b000831-15ef-44ff-9fce-3a2289d5e047
- Product NDC
- 55566-1010
- Form
- INJECTION, SOLUTION
- Composition / generic term
- ganirelix acetate
- Labeler
- Ferring Pharmaceuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220228
- Source listing expiry
- 20261231
Source-listed ingredients
- GANIRELIX ACETATE — 250 ug/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (55566-1010-1) / 1 SYRINGE in 1 BLISTER PACK / .5 mL in 1 SYRINGE · 55566-1010-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →